Managementteam - Rxlogix Managementteam - Rxlogix

Search results for:

Raj More

Raj More is the Co-Founder, Chief Executive Officer, and Chief Architect of RxLogix Corporation, where he is driving the next generation of AI-powered drug safety. Under his leadership, RxLogix has become one of the world’s leading Pharmacovigilance platforms, trusted by more than 105 organizations, including five of the world’s ten largest pharmaceutical companies and two […]

James Sterling

James Sterling is the Chief Financial Officer of RxLogix, where he leads finance operations, reporting and financial planning. James brings more than two decades of experience across corporate finance, capital markets and strategic advisory. Prior to joining RxLogix, James was chief financial officer of Bluebird Bio, a publicly-traded gene therapy pioneer with three commercial FDA-approved […]

Stefan Rupp

Stefan Rupp is Vice President of Business Development at RxLogix, where he leads strategic growth initiatives for global accounts, with a focus on expanding the company’s Pharmacovigilance (PV) products and services across key EMEA-based clients. With over 25 years of experience in the software industry, Stefan has successfully built and led global sales and business […]

Suranjan De

Suranjan is responsible for cultivating and managing strategic client relationships, driving their growth, and ensuring success and satisfaction with the RxLogix Safety Platform by aligning policy, data, technology, and innovation. Suranjan is a strategic and visionary leader with over 27 years of experience in regulatory science, pharmacovigilance, health informatics, and drug safety that spans across […]

Richard Wolf

Rich is responsible for cultivating and managing strategic client relationships, ensuring their success and satisfaction with the RxLogix Safety Platform. Rich brings over 20 years of PV Operations experience, having led global organizations and implemented safety systems at major pharmaceutical companies. His career began at Accenture, followed by 12 years at Johnson & Johnson optimizing […]